Our findings revealed an increased risk of HIV/AIDS-related mortality and poorer prognosis in older individuals, males, individuals who acquired the infection through injection drug use, individuals with baseline CD4+ T lymphocyte counts of <200 cells/μL, and individuals in WHO clinical stage IV. Here, CD4 is linked to AIDS.